NGS Research
Next-generation sequencing instruments no longer need to be limited to their immediate labs and institutions. With Meenta, you can find and submit projects to thousands of shared sequencing equipment and services.
Sign InGetting America open again begins with creating confidence and enabling citizens to go back to work and school without fear of contracting COVID. The Back to School Conference: Safely Opening Classrooms in 2021 will be a hybrid (in-person) and virtual conference to demonstrate how this is now possible. On April 13th – 14th thought leaders will assemble in Las Vegas Nevada to build strategies to keep schools open. We will profile successful approaches and showcase advanced technologies and solutions to make schools safe.
Biotech, life sciences, and other high-tech companies often need expensive instruments to conduct research and carry out testing. The problem? They don’t have a use for this equipment all the time, so it often sits idle. If shared properly, this available bandwidth could be used by many different companies, reducing their need to buy the equipment themselves. The obstacle is that companies with available equipment and the companies that need to use that equipment can’t easily connect.
Employers are also starting to use testing for specific assignments. Meenta, for example, recently developed a protocol for a New York law firm that needed to create a bubble-like environment for a weeklong trial that brought together a dozen East Coast lawyers. They took molecular tests before and after the trial and throughout the week received rapid tests administered by a nurse. No one got sick.
Boston-based online platform Meenta Inc. announced the launch of the world’s most comprehensive COVID-19 testing solution. Utilizing the nation’s largest proprietary, digitized network of FDA/EUA-certified labs and testing, Meenta is uniquely positioned to help universities, businesses, agricultural companies, manufacturers, sports, and entertainment organizations seamlessly access these labs, thus eliminating testing supply chain issues and long result wait times.
Venture Lane also put together a playbook, a 22 page document covering policies ranging from rules for visitors and the guidelines to follow in the event someone tests positive. Members are also offered a free antibody testing by one of Venture Lane’s member company, Meenta.
Boston-based online platform Meenta has launched its comprehensive COVID-19 workplace testing solution.
Online Marketplace Offers Businesses, Universities and Manufacturers Immediate Access to More Than 100 Labs and 500,000 Tests a Week
Boston-based biotech company Meenta recently launched a comprehensive COVID-19 testing solution to create the first complete return-to-work program in the United States. Its proprietary surveillance testing model lets manufacturers and distributors proactively monitor and test a fraction of their staff, resulting in an 80 to 90% savings in testing costs.
Meenta, an online platform based in Boston, US, has launched the most comprehensive testing system in the world for Covid-19.
Preventive tool helps make testing more accessible, affordable and efficient
Online Marketplace Offers Businesses, Universities and Manufacturers Immediate Access to More Than 100 Labs and 500,000 Tests a Week
Press Release (ePRNews.com) - BOSTON, Pa. - Aug 27, 2020 - Boston-based online platform Meenta Inc. today announced the launch of the world’s most comprehensive COVID-19 testing solution.
Will your reentry to the workplace involve spitting into a test tube or swabbing your nostrils, to make sure you don’t have an asymptomatic case of COVID-19?
What if scientists could plan and run experiments much faster? Meenta’s software platform is making the use of high-end research equipment far more efficient. Co-Founder & CTO Stephan Smith is excited by the massive opportunity his startup is addressing.
HBS.edu whitepaper outlining how we are solving the chicken-or-egg problem in getting a two-sided platform moving, from Andy Wu, David R. Clough, and Sasha Kaletsky.
Genome sequencing is one of the more complex subjects of life science, and those working in it have all sorts of difficulties. A recent graduate of Techstars Boston, Meenta is a startup looking to assists genome scientists in finding sequencers for research.